Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The RADiaNT study investigates whether guided meditation, using the Museâ„¢ headband and biofeedback app, can improve sleep, mood, and cognitive performance, aiming to assess its impact on mental and emotional well-being.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Guided Meditation | Experimental | This cohort will be practicing guided meditation for 5 days/week, five minutes a day for 6 weeks. Then there will be a period of testing followed by another 6 week period of practicing guided meditation. |
|
| Standard of Care | No Intervention | This cohort will be asked to complete neurologic testing at baseline, interim, and conclusion periods while conducting NO guided meditation throughout the duration of the study. |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Guided Meditation | Behavioral | Participants who complete guided meditation will be asked to meditate for 5 minutes a day, five times a week for two 6-week periods. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Duration in slow wave sleep | Total duration of sleep time spent in slow wave sleep (delta), reported in minutes | 17 weeks |
| Proportion in slow wave sleep | Proportion is the percentage of sleep time spent in slow wave sleep (delta) | 17 weeks |
| Perceived Stress Scale | Investigators will ask patients to answer the PSS questionnaire at the beginning, interim, and end of the study to see if there were any improvements in sleep quality over the intervention periods. This questionnaire is on a scale that scores 0-40, with the higher the score being a higher level of stress. | 17 weeks |
| Measure | Description | Time Frame |
|---|---|---|
| Patient Health Questionnaire 9-item (PHQ-9) | The Patient Health Questionnaire 9-item (PHQ-9) scale used to assess severity of depression. Scoring is calculated by assigning scores of 0, 1, 2, and 3 to the response categories, respectively, of "not at all," "several days," "more than half the days," and "nearly every day." Total score ranges from 0 to 27 where 0 is no depression, 1-4 is minimal depression, 5-9 is mild depression, 10-14 is moderate depression, and 15-19 is moderately severe depression and 20-27 severe depression. |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Ashley Clinical Research Coordinator | Contact | 507-284-0695 | MCRadiantStudy@mayo.edu |
| Name | Affiliation | Role |
|---|---|---|
| David Jones, MD | Mayo Clinic | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Mayo Clinic | Rochester | Minnesota | 55905 | United States |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This study will have two cohorts; one intervention cohort and one control cohort.
Not provided
Not provided
Not provided
Not provided
| 17 weeks |
| General Anxiety Disorder 7-item (GAD-7) | The General Anxiety Disorder 7-item (GAD 7) scale to assess severity of generalized anxiety disorder. Scoring is calculated by assigning scores of 0, 1, 2, and 3 to the response categories, respectively, of "not at all," "several days," "more than half the days," and "nearly every day." Total score for the seven items ranges from 0 to 21 where 0 is no anxiety, 1-4 is minimal anxiety, 5-9 is mild anxiety, 10-14 is moderate anxiety, and 15-21 is severe anxiety. | 17 weeks |
| Cognitive Performance | Investigators will test patients' cognitive performance at the beginning, interim, and conclusion of the study using Mayo Speech Test. | 17 weeks |
| Cognitive Performance | Investigators will test patients' cognitive performance at the beginning, interim, and conclusion of the study using Mayo Test Drive. | 17 weeks |